Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort
Conditions: Influenza; Hepatitis A; Typhoid; Healthy Adults Interventions: Biological: Fluzone® quadrivalent; Biological: Fluzone High Dose; Biological: Fluad; Biological: Vaqta; Biological: Typhim Vi; Biological: Vivotif Sponsors: Stanford University; National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Influenza | Influenza Vaccine | Research | Typhoid | Typhoid Vaccine | Vaccines